Reduced collagenase gene expression in fibroblasts from hypertrophic scar tissue

British Journal of Dermatology

Volumn 134, Issue 5, 1996, Pages 863-868

  Arakawa, M ^b   Hatamochi, A ^a,c   Mori, Y ^a   Mori, K ^a   Ueki, H ^a   Moriguchi, T ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; MALE; PRIORITY JOURNAL; SCHOOL CHILD; WOUND HEALING;

EID: 0029962416     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb06316.x     Document Type: Article

References (35)

1. Pinnell SR. Regulation of collagen synthesis. J Invest Dermatol 1982; 79(Suppl. I): 73s-6s.
2. Stricklin GP, Li L, Nanney LB. Localization of mRNAs representing interstitial collagenase, 72-kDa gelatinase, and TIMP in healing porcine burn wounds. J Invest Dermatol 1994; 103: 352-8.
3. Craig RD, Schofield JD, Jackson DS. Collagen biosynthesis in normal and hypertrophic scars and kcloids as a function of the duration of the scar. Br J Surg 1975; 62: 741-4.
4. Murray JC, Pollack SV, Pinnell SR. Keloids: a review. J Am Acad Dermatol 1981; 4: 461-70.
5. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992; 14: 455-63.
6. Birkedal-Hansen H, Moore WGI, Bodden MK et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197-250.
7. Stricklin GP, Welgus HG. Human skin libroblast collagenase inhibitor: purification and biochemical characterization. J Biol Chem 1983; 258: 12252-8.
8. Welgus HG, Stricklin GP. Human skin fibroblast collagenase inhibitor: comparative studies in human connective tissues, serum and amniotic fluid. J Biol Chem 1983; 258: 12259-64.
9. Cohen IK, Keiser HR, Sjoerdsma A. Collagen synthesis in human keloid and hypertrophic scar. Surg Forum 1971; 22: 488-9.
10. Uitto J, Perejda AJ, Abergel RP et al. Altered steady state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. Proc Natl Acad Sci USA 1985; 82: 5935-9.
11. Chahary A, Scott PG, Mlhotra S et al. Differential expression of type I and type III procollagen mRNA in human hypertrophic burn fibroblasts. Biomed Lett 1992; 47: 169-84.
12. Ackerman AB. Histologic Diagnosis of Inflammatory Skin Disease. Philadelphia: Lea & Febiger, 1978; 727-31.
13. Arakawa M, Hatamochi A, Takeda K, Ueki H. Increased collagen synthesis accompanying elevated m-RNA levels in cultured Werner's syndrome fibroblasts. J Invest Dermatol 1990; 94: 187-90.
14. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-9.
15. Hatamochi A, Aumailley M, Mauch C et al. Regulation of collagen VI expression in tibroblasts. Effects of cell density, cell-matrix interactions and chemical transformation. J Biol Chem 1989; 264: 3494-9.
16. 1 (I) collagen chain. Nucleic Acid Res 1982; 10: 5925-34.
17. Miskulin M, Dalgleish R, Kluve-Beckerman B et al. Human type III collagen genes expression is coordinately modulated with the type I collagen genes during fibroblast growth. Biochemistry 1986; 25: 1408-13.
18. Angel P, Poting A, Mallick U et al. Induction of metallothionein and other mRNA species by carcinogens and tumor promoters in primary human skin fibroblasts. Mol Cell Biol 1986; 6: 1760-6.
19. Carmichael DF, Sommer A, Thompson RC et al. Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA 1986; 83: 2407-11.
20. Gunning P, Ponte P, Okayama H et al. Isolation and characterization of full-length cDNA clones for human α-, β- and Γ-actin mRNA: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol 1983; 3: 787-95.
21. Takeda K, Hatomochi A, Ueki H et al. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 1994; 103: 359-63.
22. Ohsawa S, Hori H, Hata R, Nagai Y. Stimulation of the collagen metabolism of articular chondrocytes in culture by a factor derived from polymorphonuclear leukocytes. Biomed Res 1984; 5: 177-86.
23. Varedi M, Tredget EE, Scott PG et al. Alteration in cell morphology triggers transforming growth factor-β collagenase, and tissue inhibitor of metalloproteinases-I expression in normal and hypertrophic scar fibroblasts. J Invest Dermatol 1995; 104: 118-23.
24. Hembry RM, Ehrlich HP. Immunolocalization of collagenase and tissue inhibitor of metalloproteinases (TIMP) in hypertrophic scar tissue. Br J Dermatol 1986; 115: 409-20.
25. Lafuma C, Nabout RAE, Crechet F et al. Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skir fibroblast cultures derived from radiation-induced skin fibrosis. J Invest Dermatol 1994; 102: 945-50.
26. Scharffetter K, Heckmann M, Hatamochi A et al. Synergistic effect of tumor necrosis factor-α and interferon-I' collagen synthesis of human skin fibroblasts in vitro. Exp Cell Res 1989; 181: 409-19.
27. Brenner DA, O'Hara M, Angel P et al. Prolonged activation of jun and collagenase genes by tumour necrosis factor-α. Nature 1989; 337: 661-3.
28. Bauer EA, Cooper TW, Huang JS et al. Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc Natl Acad Sci USA 1985; 82: 4132-6.
29. Edwards DR, Murphy G, Reynolds JJ et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987; 6: 1899-904.
30. Angel P, Baumann I, Stein B et al. 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol Cell Biol 1987; 7: 2256-66.
31. Ghahary A, Shen YJ, Scott PG et al. Enhanced expression of mRN A for transforming growth factor-β type I and type III procollagen in human post-burn hypertrophic scar tissues. J Lab Clin Med 1993; 122: 465-73.
32. 1 is reduced in hypertrophic scar and normal dermal fibroblasts following serial passage in vitro. J Invest Dermatol 1994; 103: 684-6.
33. Jonat C, Rahmsdorf HJ, Park KK et al. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990; 62: 1189-204.
34. Unemori EN, Mauch C, Hoeffler W et al. Constitutive activation of the collagenase promoter in recessive dystrophic epidermolysis bullosa fibroblasts: role of endogenously activated AP-1. Exp Cell Res 1994; 211: 212-18.
35. Hatamochi A, Arakawa M, Mori K, Ueki H. Elevated collagenase mRNA levels in cutis laxa fibroblasts result from an increased transcription rate of the corresponding gene. J Dermatol Sci 1994; 8 (Suppl. 1): 75 (Abstract).